Caldecrin inhibited TNF-α-stimulated RANKL overexpression in RA fibroblasts, suggesting that caldecrin inhibits inflammatory cytokine-induced RANKL expression in RA. Here, TNFSF11 is linked to rheumatoid arthritis.